Cancer therapy has been revolutionized by two revolutionary drugs, osimertinib and ramucirumab.A synergistic method that aims the growth and propagation of malignant cells is offered when they are used in combination.This article will delve into the various aspects of osimertinib and ramucirumab, including their unique characteristics, modes of operation, and the potential benefits of their combined application.A targeted therapy, osimertinib, blocks the activity of the EGFR (epidermal growth factor receptor) tyrosine kinase, a protein that is participating in the growth and proliferation of malignant cells.osimertinib is primarily used for the…
